RPH S.C. Ropharma S.A.
S.C. Ropharma S.A., together with its subsidiaries, operates a chain of pharmacies in Romania. The company offers medicines on prescription, over-the-counter (OTC) medications, food supplements, dermato-cosmetics, cosmetics, and medical devices, as well as other healthcare products dispensed through pharmacies. It also provides medical services in various areas, including oncology, hematology, oncological surgery and HIPEC, bariatric surgery, thoracic surgery, and robotic surgery; and operates renal transplant and cardiovascular disease center. In addition, the company offers products with lactoferrin, vitamins and minerals in tablets/sachets, plant extracts, pre and probiotics, product with natural enzyme, and cosmetics. Further, it is involved in retail and distribution of pharmaceutical products; production of pharmaceutical products, food supplements, and dermocosmetics; and provision of medical ang hospital services. The company was incorporated in 1952 and is headquartered in Brasov, Romania.…
Industry Peers
Pharmaceutical RetailersKey Statistics
About S.C. Ropharma (BVB: RPH)
›
S.C. Ropharma (BVB: RPH) is listed on Bucharest Stock Exchange, where its shares trade in RON. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 1,262 employees.
The shares were at 0.2400 RON on 20 November 2026, up 50.9% over 52 weeks. Its 52-week range is 0.1500 RON to 0.2880 RON: the price is 16.7% below the high and 60.0% above the low.
Its market capitalisation is 122.70M RON.
S.C. Ropharma reports return on equity of -0.7%, an operating margin of 1.3% and revenue up 19.7% year over year.
Its debt exceeds its cash by 128.11M RON, a debt-to-equity ratio of 0.66. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.